ARMISTICE CAPITAL, LLC

Q4 2020 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2020
Date filed
2/16/2021
Form type
13F-HR
Num holdings
104
Total value ($000)
$2,234,824
Net value change ($000)
-521,845 (-18.9%)
New positions
34
Sold out positions
29
Turnover %
40.5%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q3 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
WMT 53,368 NEW
ORLY 40,995 NEW
ULTA 39,715 NEW
BIIB 34,806 122.7%
ENTA 33,099 138.0%
Mirati Therapeutics, Inc. 31,846 114.2%
TGT 31,544 NEW
FIVE 31,154 197.5%
BGS 29,505 NEW
BURL 25,486 NEW
Top Reduces (Value $000, Stocks/ETFs)
ALXN -57,215 -100.0%
MRK -43,466 -100.0%
WSM -40,246 -100.0%
AMAG -38,728 -100.0%
LOW -34,224 -100.0%
CVS -29,200 -100.0%
AZO -27,697 -45.9%
ENR -24,425 -37.2%
CL -23,145 -100.0%
DLTR -20,163 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type